Does multi-species Borrelia IgM reactivity prove simultaneous infection?

In an 83-year-old man, a multi-species Borrelia IgM pattern should be interpreted as a serologic finding—not as proof of multiple active infections—alongside symptoms, exposure history, timing, and validated diagnostic testing.

Serologic interpretation

• Conserved or homologous antigens can generate cross-reactive antibody responses across Borrelia species. Relevant targets include conserved VlsE/C6 regions and flagellin/FlaB (p41).
• p41 epitopes may be shared between Lyme borreliae and relapsing-fever Borrelia such as B. hermsii. A single antibody response can therefore yield apparent reactivity to antigens attributed to more than one species.
• Human sera have shown IgM reactivity to OspC from B. afzelii, B. garinii, and B. burgdorferi without establishing whether the pattern represents cross-reaction or concurrent infection.

Mechanistic and diagnostic implications

• Cross-reactivity is antigen- and assay-dependent, not universal. VlsE-related conserved sequences support cross-genospecies recognition, whereas other targets can show limited or variable cross-binding.
• IgM is especially vulnerable to misleading interpretation: conserved p41 can react with antibodies unrelated to Borrelia, including antibodies associated with syphilis, and clinical guidance recognizes cross-reactive antibodies as a source of false-positive serology.
• CDC guidance recommends disregarding isolated IgM results after 30 days of symptoms because late IgM positivity has a high false-positive risk. Antibodies may also represent prior exposure rather than active infection.

Clinical implications

• Species-level or simultaneous-infection diagnoses require independent, species-appropriate confirmation integrated with the clinical syndrome and epidemiology. Validated two-tier Lyme testing is preferred over isolated antigen/species IgM signals; appropriately designed PCR may support species identification in a suitable specimen, although a negative result does not exclude Lyme borreliosis.

Bottom line

• Multi-species Borrelia IgM reactivity can result from shared-antigen cross-reactivity and does not, by itself, demonstrate simultaneous active infection with each reactive species.